Robbins Andrew R 4
4 · Cogent Biosciences, Inc. · Filed Oct 27, 2020
Insider Transaction Report
Form 4
Robbins Andrews R
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2020-10-23+7,442,421→ 7,442,421 totalExercise: $2.79Exp: 2030-10-22→ Common Stock (7,442,421 underlying)
Footnotes (1)
- [F1]This stock option shall vest as follows: 25% on the first anniversary of the date of grant; then in equal monthly installments over 36 months.